Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AZNCF - IPO Update: AlloVir Proposes Terms For $251 Million IPO


AZNCF - IPO Update: AlloVir Proposes Terms For $251 Million IPO

Quick Take

AlloVir (ALVR) intends to raise $251 million from the sale of its common stock in an IPO, according to an amended registration statement.

The company is a mid stage firm developing drug treatments for virus conditions.

ALVR is preparing to enter Phase 3 trials and has an enviable position as a virus-focused biopharma with a promising pipeline in an area that is receiving strong interest by investors, researchers and government entities.

Although the IPO isn’t cheap, for life science investors with a patient hold time frame, the IPO is worth

Read more ...

Stock Information

Company Name: AstraZeneca Plc
Stock Symbol: AZNCF
Market: OTC
Website: astrazeneca.com

Menu

AZNCF AZNCF Quote AZNCF Short AZNCF News AZNCF Articles AZNCF Message Board
Get AZNCF Alerts

News, Short Squeeze, Breakout and More Instantly...